(Q45205085)

English

Immunohistochemical analysis of E-cadherin and zeste homolog 2 expression in endoscopic ultrasound-guided fine-needle aspiration of pancreatic adenocarcinoma

scientific article published on 14 May 2013

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

10 December 2017

Immunohistochemical analysis of E-cadherin and zeste homolog 2 expression in endoscopic ultrasound-guided fine-needle aspiration of pancreatic adenocarcinoma (English)

1 reference

Europe PubMed Central

PubMed publication ID

10 December 2017

immunohistochemistry

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Ling Gao

1

1 reference

Europe PubMed Central

PubMed publication ID

10 December 2017

Tatjana Antic

2

1 reference

Europe PubMed Central

PubMed publication ID

10 December 2017

Elizabeth Hyjek

3

1 reference

Europe PubMed Central

PubMed publication ID

10 December 2017

Can Gong

4

1 reference

Europe PubMed Central

PubMed publication ID

10 December 2017

Jeffrey Mueller

5

1 reference

Europe PubMed Central

PubMed publication ID

10 December 2017

Irving Waxman

6

1 reference

Europe PubMed Central

PubMed publication ID

10 December 2017

Richard M DeMay

7

1 reference

Europe PubMed Central

PubMed publication ID

10 December 2017

Ward Reeves

8

1 reference

Europe PubMed Central

PubMed publication ID

10 December 2017

publication date

14 May 2013

1 reference

Europe PubMed Central

PubMed publication ID

10 December 2017

Cancer Cytopathology

1 reference

Europe PubMed Central

PubMed publication ID

10 December 2017

121

1 reference

Europe PubMed Central

PubMed publication ID

10 December 2017

11

1 reference

Europe PubMed Central

PubMed publication ID

10 December 2017

644-652

1 reference

Europe PubMed Central

PubMed publication ID

10 December 2017

EUS-guided FNA of solid pancreas tumors

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21310

21 January 2018

Systematic review of immunohistochemical biomarkers to identify prognostic subgroups of patients with pancreatic cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21310

21 January 2018

The tumor-suppressor function of E-cadherin

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21310

21 January 2018

Loss of E-cadherin expression and outcome among patients with resectable pancreatic adenocarcinomas.

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21310

21 January 2018

Tissue biomarkers for prognosis in pancreatic ductal adenocarcinoma: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21310

21 January 2018

Anti-VEGF treatment-resistant pancreatic cancers secrete proinflammatory factors that contribute to malignant progression by inducing an EMT cell phenotype.

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21310

21 January 2018

Contribution of epithelial-to-mesenchymal transition and cancer stem cells to pancreatic cancer progression

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21310

21 January 2018

Epithelial to mesenchymal transition contributes to drug resistance in pancreatic cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21310

21 January 2018

Histone methyltransferases in cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21310

21 January 2018

Implications of enhancer of zeste homologue 2 expression in pancreatic ductal adenocarcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21310

21 January 2018

Regulation of pancreatic tumor cell proliferation and chemoresistance by the histone methyltransferase enhancer of zeste homologue 2.

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21310

21 January 2018

Activated KrasG¹²D is associated with invasion and metastasis of pancreatic cancer cells through inhibition of E-cadherin.

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21310

21 January 2018

Molecular mechanisms involved in the synergistic interaction of the EZH2 inhibitor 3-deazaneplanocin A with gemcitabine in pancreatic cancer cells

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21310

21 January 2018

RAS oncogenic signal upregulates EZH2 in pancreatic cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21310

21 January 2018

MEK-ERK pathway regulates EZH2 overexpression in association with aggressive breast cancer subtypes

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21310

21 January 2018

EZH2 couples pancreatic regeneration to neoplastic progression

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21310

21 January 2018

EZH2 links pancreatitis to tissue regeneration and pancreatic cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21310

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/CNCY.21310

1 reference

Europe PubMed Central

PubMed publication ID

10 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

10 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45205085&oldid=2070078185"